Kairos Pharma Ltd.

KAPA | AMEX

Price Alert Chart Builder DCF Calculator

$1.74

-$0.05 (-2.79%)

Sep 22, 2026, 11:12 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022
Cash & Equivalents	2.63M	3.68M	4.49M	5.58M	3.03M	3.62M	1.27M	3.22M	21K	40K	93K	99K	232K	357K	437K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.28M	1.28M	1.09M	1.31M	1.69M	1.71M	1.38M	n/a	690K	571K	482K	410K	258K	129K	57K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.52M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	412K	768K	896K	1.08M	1.81M	55K	38K	-1.52M	n/a	n/a	8K	n/a	n/a	n/a	n/a
Total Current Assets	3.17M	4.44M	5.39M	6.66M	4.84M	6.05M	4.17M	4.74M	38K	59K	101K	116K	258K	374K	437K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	22K	62K	102K	142K	182K	222K	262K	302K	342K	382K	422K	462K	502K	542K
Total Long-Term Assets	1.28M	1.3M	1.15M	1.41M	1.83M	1.89M	2.05M	262K	992K	913K	864K	832K	720K	631K	599K
Total Assets	4.46M	5.74M	6.54M	8.07M	6.67M	7.94M	6.22M	5M	1.03M	972K	965K	948K	978K	1.01M	1.04M
Account Payables	265K	431K	199K	402K	676K	805K	992K	1.53M	2.9M	2.71M	2.4M	2.21M	1.93M	1.73M	1.63M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	142K	106K	4K	n/a	4K	4K	4K	4K
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	265K	431K	199K	402K	676K	805K	992K	1.67M	3.01M	2.72M	2.41M	2.21M	1.94M	1.74M	1.63M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	677K	657K	638K	612K	602K	592K	582K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	448K	n/a	677K	657K	638K	612K	602K	592K	582K
Total Liabilities	265K	431K	199K	402K	676K	805K	1.44M	1.67M	3.68M	3.37M	3.04M	2.82M	2.54M	2.33M	2.22M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	142K	783K	661K	638K	616K	606K	596K	586K
Book Value	4.19M	5.31M	6.34M	7.66M	6M	7.13M	4.78M	3.33M	-2.65M	-2.4M	-2.08M	-1.87M	-1.56M	-1.33M	-1.18M
Book Value Per Share	1.37	1.77	2.41	2.66	2.44	3.14	2.43	2.14	-1.45	-1.59	-1.39	-1.17	-1.06	-0.90	-0.80
Common Stock	21K	21K	21K	21K	18K	16K	14K	13K	11K	11K	11K	10K	103K	103K	10K
Retained Earnings	-17.3M	-15.92M	-14.26M	-12.9M	-11.5M	-10.08M	-8.82M	-7.84M	-6.79M	-6.54M	-6.21M	-5.09M	-4.78M	-4.55M	-4.4M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	484K	n/a	n/a	n/a	n/a	n/a	0	n/a	0	n/a
Shareholders Equity	4.19M	5.31M	6.34M	7.66M	6M	7.13M	4.78M	3.33M	-2.65M	-2.4M	-2.08M	-1.87M	-1.56M	-1.33M	-1.18M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a